Trial: 201903017

A PHASE II, OPEN-LABEL, MULTICENTER, RANDOMIZED STUDY OF THE EFFICACY AND SAFETY OF RO7198457 IN COMBINATION WITH PEMBROLIZUMAB VERSUS PEMBROLIZUMAB IN PATIENTS WITH PREVIOUSLY UNTREATED ADVANCED MELANOMA

Phase

II

Principal Investigator

Ansstas, George

Disease Site

Melanoma, Skin

Learn more about this study at: clinicaltrials.gov